- September 12, 2024
-
-
Loading
Loading
The Charles L. and Miki N. Grant Cancer Center for Hope medical team is the first in the U.S. to treat cancer patients using the Accuray Radixact System with VitalHold technology.
The new VitalHold feature will provide a resource for effectively positioning the patient and monitoring the accuracy of that positioning throughout their treatment, enhancing precision in radiation delivery. The new system is housed at the Cancer Center for Hope – Port Orange.
Halifax Health augmented its Radixact System with the Accuray proprietary ClearRT helical CT imaging and Synchrony real-time adaptive delivery technologies. The comprehensive radiotherapy delivery system, in combination with VitalHold, is designed to facilitate treatment of a wider range of cancer cases including breast cancer, faster and with less harm to patients.
“With the estimated number of new cancer cases in the U.S. anticipated to increase by about 35% between the year 2022 and 2040, it’s important that medical teams have the resources they need to offer the best possible care today and into the future," said Suzanne Winter, president and CEO of Accuray. "... We are proud to partner with the Halifax Health team as they continue to advance patient centered cancer care in Volusia County. Their treatment of the first patients in the U.S. using VitalHold on the Radixact System shows their dedication to investing in options for care that have the potential to meaningfully improve the lives of their patients.”
The VitalHold feature incorporates a fully integrated and automated surface-guided radiotherapy solution, Catalyst+ HD from C-RAD, on the Radixact System that offers multiple benefits for medical teams and their patients. SGRT is a technology that supports highly accurate positioning by scanning a patient’s body surface with a high-resolution camera and reconstructing it as a 3D image in real-time. The reconstructed image enables clinicians to easily visualize the difference between the current body position and the target position, helping to ensure high reproducibility of the patient position during treatment.
“As the first and only center in the U.S. to treat cancer using the Radixact System and VitalHold, we are demonstrating our commitment to providing the highest level of care to the people in our community,” said Jeff Feasel, President and CEO of Halifax Health. “The full-featured Radixact® System provides us with the tools we need to think differently about how we use radiation therapy within our practice. Moving forward, we will continue to lengthen and improve the quality of patients’ lives, making it possible to eliminate some of the fear associated with a cancer diagnosis.”
